- Drug Coverage
- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Safety & Recalls
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Seniors sound off on medical care
A survey of 321 seniors 65 and older revealed that 61% think the healthcare reform bill has weakened Medicare in the year since it became law.
A survey of 321 seniors 65 and older revealed that 61% think the healthcare reform bill has weakened Medicare in the year since it became law. At the same time, 57% of those surveyed say they will take advantage of a free physical exam and personal wellness plan benefit included in the bill that went into effect this year.
Moreover, 73% of seniors surveyed think the health care bill will continue to weaken Medicare over the long term. When asked about attempts under way in the U.S. House of Representatives to defund the bill, 43% of seniors surveyed support defunding the bill entirely and 29% think only certain provisions of the bill should be defunded.
The survey was fielded from March 18-21, 2011 by Extend Health, Inc., which operates a private Medicare exchange. The company says the bill does not cut any Medicare benefits, and instead adds some benefits, including the previously mentioned free physical exam and other free preventative care services.
FDA Updates for Week of May 13: First Bispecific Antibody for Solid Tumor
May 18th 2024The FDA has approved a new type of bispecific antibody to treat small cell lung cancer and an additional indication for Breyanzi for patients with follicular lymphoma. The agency has set review date for gene therapy for enzyme deficiency. In addition, Biogen have Eisai hve begun a rolling submission of subcutaneous Leqembi for Alzheimer’s disease.
Read More
Omega-3s For Dry Eye Disease? Not the Answer According to This Study
May 17th 2024Some research has suggested that omega-3 fatty acid supplements could help treat dry eye disease. But Korean investigators reported results from a randomized clinical trial this week in JAMA Ophthalmology tthat showed no benefit.
Read More
